Lacrofarm

Sodium hydrogen carbonate, potassium chloride, sodium chloride, and macrogol 3350, the active ingredients in Lacrofarm, are an unknown drug class presented as an oral solution for oral use. It is intended to support electrolyte balance and provide osmotic laxative action in adults requiring rehydration or bowel preparation.

GNH USA supplies Lacrofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring product integrity from manufacturing to delivery.

Lacrofarm is used to address conditions related to fluid and electrolyte balance as well as bowel cleansing.

- Dehydration: helps restore fluid and electrolyte levels in individuals with mild to moderate dehydration. - Constipation: provides osmotic laxative effect to relieve occasional constipation. - Bowel preparation: assists in cleansing the colon before diagnostic or surgical procedures.

Lacrofarm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal bloating: feeling of fullness or distension. - Diarrhea: loose stools due to osmotic activity. - Flatulence: increased intestinal gas. - Electrolyte imbalance: mild changes in serum sodium or potassium. - Abdominal discomfort: cramping or mild pain.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss leading to dizziness or fainting. - Significant electrolyte disturbances: hypernatremia or hyperkalemia requiring medical attention. - Allergic reaction: rash, itching, or swelling of the face, lips, or throat. - Severe abdominal pain: persistent or worsening pain. - Intestinal obstruction: signs of blockage such as vomiting and inability to pass stool.

When using Lacrofarm, consider the following precautions to ensure safe and effective use.

- Assess hydration status: evaluate the degree of dehydration before administration. - Monitor electrolyte levels: check serum sodium and potassium during prolonged use. - Renal impairment: use with caution in patients with reduced kidney function. - Hypersensitivity: avoid if known allergy to any component exists. - Dosage limits: do not exceed the recommended volume without medical guidance. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lacrofarm can interact with other medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Concurrent osmotic laxatives: may cause excessive fluid loss. - High‑dose potassium supplements: risk of hyperkalemia. - Diuretics that alter electrolytes: can exacerbate electrolyte imbalance.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: monitor blood pressure due to potassium shifts. - ACE inhibitors: watch for potassium elevation. - NSAIDs: may affect renal function and electrolyte handling.